Rabies vaccination: Protecting vulnerable travelers

Infections in Medicine

Volumn 19, Issue 12, 2002, Pages 561-565

  Briggs, Deborah J ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Rabie; Travel medicine; Vaccination; Zoonoses

Indexed keywords

CHLOROQUINE; NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

AFRICA; AGED; ARTICLE; ASIA; CAUSE OF DEATH; CHILD; CLINICAL TRIAL; CONSULTATION; ENDEMIC DISEASE; FATALITY; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; MALARIA; PATIENT COUNSELING; RABIES; RABIES VIRUS; SOUTH AND CENTRAL AMERICA; TRAVEL; UNITED STATES; VACCINATION;

EID: 0036906119     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med. 1998;128: 922-930.
2. Hanlon CA, Olson JG, Clark CJ. Prevention and education regarding rabies in human beings. National Working Group on Rabies Prevention and Control. J Am Vet Med Assoc. 1999;215:1276-1280.
3. World Health Organization world survey of rabies for the year 1998. No. 34. WHO/CDS/CSR/APH/99.6. World Health Organization: Geneva; 2000.
4. Krause E, Grundmann H, Hatz C. Pretravel advice neglects rabies risk for travelers to tropical countries. J Travel Med. 1999;6:163-167.
5. Hatz CF, Bidaux JM, Eichenberger K, et al. Circumstances and management of 72 animal bites among long-term residents in the tropics. Vaccine. 1995;13:811-815.
6. Arguin PM, Krebs JW, Mandel E, et al. Survey of rabies preexposure and postexposure prophylaxis among missionary personnel stationed outside the United States. J Travel Med. 2000;7:10-14.
7. Human rabies - New Hampshire, 1996. MMWR. 1997;46:267-270.
8. Smith JS, Fishbein DB, Rupprecht CE, Clark K. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med. 1991;324:205-211.
9. Human rabies prevention - United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1999;48:1-21.
10. WHO Expert Committee on Rabies. World Health Organ Tech Rep Ser. 1992;824:1-84.
11. Hanlon CA, Niezgoda M, Morrill PA, Ruprecht CE. The incurable wound revisited: progress in human rabies prevention? Vaccine. 2001;19:2273-2279.
12. Human rabies - Kenya. MMWR. 1983;32:494-495.
13. Briggs DJ, Dreesen DW, Nicolay U, et al. Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine. 2000;19:1055-1060.
14. Dreesen DW, Fishbein DB, Kemp DT, Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine. 1989;7:397-400.
15. Briggs DJ, Schwenke JR. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine. 1992;10:125-129.
16. Mastroeni I, Vescia N, Pompa MG, et al. Immune response of the elderly to rabies vaccines. Vaccine. 1994;12:518-520.
17. Madrid Y. When appearances deceive: some considerations in improving access to rabies post-exposure treatment. In: Intradermal application of rabies vaccines. Report of a WHO Consulation. Bangkok, Thailand. WHO/CDS/CSR/APH/2000.5:18-21.
18. World Health Organization. Intradermal application of rabies vaccines. Report of a WHO consultation, Bangkok, Thailan June 5-6, 2000. WHO/CDS/CDSRAPH/2000.05. Geneva: World Health Organization; 2001.
19. World Health Organization. Strategies for the control and elimination of rabies in Asia. Report of a WHO Interregional Consultation. July 17-21, 2001. Geneva.
20. Fescharek R, Schwarz S, Quast U, et al. Postexposure rabies prophylaxis: when the guidelines are not respected. Vaccine. 1991;9:868-872.
21. Hemachudha T, Mitrabhakdi E, Wilde H, et al. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin Infect Dis. 1999;28:143-144.
22. Eng TR, Fishbein DB, Talamante HE, et al. Urban epizootic of rabies in Mexico: epidemiology and impact of animal bite injuries. Bull World Health Organ. 1993;71:615-624.
23. Thongcharoen P, Wasi C, Sirikawin S, et al. Rabies and post-exposure prophylaxis in Thai children. Asia Pac J Allergy Immunol. 1989;7:41-46.
24. Sabchareon A, Chantavanich P, Pasuralertsakul S, et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J. 1998;17:1001-1007.
25. Lang J, Hoa DQ, Gioi NV, et al. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparable randomized trial. Trans R Soc Trop Med Hyg. 1999;93:208-213.
26. Deshpande A, Briggs DJ, Banzhoff A. Investigation of immune resonse to purified chick embryo cell tissue culture rabies vaccine (PCECV) in HIV infected individuals using a simulated post-exposure regimen. In: Dodet B, Meslin FX, Heseltine E, eds. Rabies Control in Asia. London: John Libbey Eurotext; 2001:58-60.
27. Thisyakorn U, Pancharoen C, Ruxrungtham K, et al. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin Infect Dis. 2000;30:218.